Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FACBC PET-CT for Characterization of Primary Prostate Cancer
NCT00917865Phase 2Terminated
- Start
- Apr 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of fluciclovine f 18 in prostate cancer (PCa). Primary endpoint: Diagnostic Performance Per Sextant at Each Time Point by Visual Analysis at 40 minutes. Started Apr 2008; status: terminated.
02
Drugs
fluciclovine f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00917865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917865.